Combining the European Society of Cardiology troponin algorithms and HEART Score for ruling out acute coronary syndrome in unselected patients presenting with acute chest pain: The WESTCOR study
Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients